Hyperferritinemia: A Diagnostic Marker for Disseminated Neonatal Herpes Simplex Virus Infection?

Pediatr Ann. 2021 Jun;50(6):e264-e267. doi: 10.3928/19382359-20210513-01. Epub 2021 Jun 1.

Abstract

Although the prognosis of neonatal herpes simplex virus (HSV) infection has improved with intravenous acyclovir, the morbidity and mortality of disseminated disease remains high. Transaminitis and thrombocytopenia have been reported to be sensitive markers of neonatal HSV disease; however, early diagnosis remains a challenge due to a lack of specific clinical and laboratory indicators for this disease process. Ferritin, an acute phase reactant known for its use in diagnosing hemophagocytic lymphohistiocytosis, has recently been reported as extremely elevated in neonates with disseminated HSV due to its high inflammatory nature. We report three cases of neonates at a single institution with hyperferritinemia in the setting of disseminated HSV. Based on this case series, we discuss whether ferritin can be used as an early diagnostic marker in the setting of suspected neonatal HSV disease. [Pediatric Annals. 2021;50(6):e264-e267.].

Publication types

  • Case Reports

MeSH terms

  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use
  • Female
  • Herpes Simplex* / complications
  • Herpes Simplex* / diagnosis
  • Herpes Simplex* / drug therapy
  • Humans
  • Hyperferritinemia* / etiology
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Complications, Infectious* / drug therapy

Substances

  • Antiviral Agents
  • Acyclovir

Supplementary concepts

  • Neonatal herpes